Home / Levodopa and Decarboxylase Inhibitor / Norway
NO ATC N04BA02 · updated 2 Nov 2026
Levodopa and Decarboxylase Inhibitor shortage in Norway
Is there a Levodopa and Decarboxylase Inhibitor shortage in Norway?
Yes. As of 2 Nov 2026, 1 Levodopa and Decarboxylase Inhibitor product is reported short in Norway, the first since 15 Sep 2026. The company estimate for the return is 8 Nov 2026. Main reason: manufacturing problem.
Also short in Canada, Czechia, Sweden. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Sinemet 25/100 25 mg/100 mg tablett, 100 stk boks | N.V. Organon - Kloosterstraat | 15 Sep 2026 | 8 Nov 2026 | Manufacturing problem Produksjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).